AB
Ashok Bansal
About Ashok Bansal
Data last updated:
Ashok Bansal was a Director at Ipcan Generic Health Care Private Limited (2003–2010), Director at Systochem Laboratories Limited (2017–2020) and Director at Gleanboots Life Science Private Limited (2007–2011), and held 1 more directorship. The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Oct 2003 | 2003 | ₹25,500 (FY 2020) | Active | |
| Director | 01 Jun 2017 | 1995 | ₹43.32 Cr (FY 2025) | Active | |
| Director | 23 Mar 2007 | 1999 | ₹1.72 Cr (FY 2025) | Active | |
| Director | 01 Jun 2003 | 1995 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashok Bansal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashok Bansal
Ashok Bansal was first appointed on 01 Jun 2003 as Director at Silva Drugs India Private Limited. The most recent appointment on record is 01 Jun 2017 at Systochem Laboratories Limited.
Ashok Bansal held 4 earlier board appointments: Ipcan Generic Health Care Private Limited (Director, 21 Oct 2003 to 30 Nov 2010); Systochem Laboratories Limited (Director, 01 Jun 2017 to 25 Feb 2020); Gleanboots Life Science Private Limited (Director, 23 Mar 2007 to 15 Jan 2011); Silva Drugs India Private Limited (Director, from 01 Jun 2003).